NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

ABBV

Abbvie Inc

May 16 • 04:00PM ET

184.02

Dollar change +2.34
Percentage change 1.29	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: JNJ PFE MRK LLY BMY GILD AMGN REGN VRTX BIIB

| Held by: VTI VOO SPY IVV VTV SCHD XLV VIG VYM VHT

Scroll to Statements

Index	S&P 500	P/E	78.47	EPS (ttm)	2.35	Insider Own	0.11%	Shs Outstand	1.77B	Perf Week	-0.31%
Market Cap	325.05B	Forward P/E	13.15	EPS next Y	13.99	Insider Trans	-12.62%	Shs Float	1.76B	Perf Month	7.19%
Income	4.16B	PEG	5.17	EPS next Q	3.22	Inst Own	74.17%	Short Float	1.12%	Perf Quarter	-4.59%
Sales	57.37B	P/S	5.67	EPS this Y	20.77%	Inst Trans	1.44%	Short Ratio	2.43	Perf Half Y	7.56%
Book/sh	0.80	P/B	228.89	EPS next Y	14.46%	ROA	2.92%	Short Interest	19.80M	Perf Year	13.88%
Cash/sh	2.93	P/C	62.80	EPS next 5Y	15.17%	ROE	88.15%	52W Range	153.58 - 218.66	Perf YTD	3.56%
Dividend Est.	6.51 (3.54%)	P/FCF	21.13	EPS past 5Y	-14.67%	ROI	6.30%	52W High	-15.84%	Beta	0.48
Dividend TTM	6.38 (3.47%)	Quick Ratio	0.64	Sales past 5Y	12.19%	Gross Margin	70.80%	52W Low	19.82%	ATR (14)	6.63
Dividend Ex-Date	Apr 15, 2025	Current Ratio	0.76	EPS Y/Y TTM	-30.21%	Oper. Margin	30.74%	RSI (14)	46.66	Volatility	4.15% 3.17%
Employees	55000	Debt/Eq	49.22	Sales Y/Y TTM	5.45%	Profit Margin	7.24%	Recom	1.90	Target Price	214.88
Option/Short	Yes / Yes	LT Debt/Eq	45.44	EPS Q/Q	-6.05%	Payout	263.15%	Rel Volume	0.75	Prev Close	181.68
Sales Surprise	3.22%	EPS Surprise	3.39%	Sales Q/Q	8.39%	Earnings	Apr 25 BMO	Avg Volume	8.16M	Price	184.02
SMA20	-1.14%	SMA50	-5.01%	SMA200	-2.80%	Trades		Volume	6,140,012	Change	1.29%

Date	Action	Analyst	Rating Change	Price Target Change
May-14-25	Downgrade	Citigroup	Buy → Neutral	$205
Apr-22-25	Initiated	Cantor Fitzgerald	Overweight	$210
Dec-10-24	Resumed	BofA Securities	Neutral	$191
Dec-05-24	Downgrade	Daiwa Securities	Outperform → Neutral	$180
Nov-22-24	Upgrade	Leerink Partners	Market Perform → Outperform	$206
Nov-15-24	Initiated	Wolfe Research	Outperform	$205
Nov-04-24	Upgrade	Argus	Hold → Buy
Oct-17-24	Initiated	Bernstein	Mkt Perform	$203
Jun-05-24	Upgrade	HSBC Securities	Hold → Buy	$185
May-17-24	Initiated	Cantor Fitzgerald	Overweight	$200
Jan-29-24	Upgrade	William Blair	Mkt Perform → Outperform
Dec-18-23	Downgrade	HSBC Securities	Buy → Hold
Dec-11-23	Upgrade	Goldman	Neutral → Buy
Nov-09-23	Initiated	Deutsche Bank	Hold	$150
Oct-30-23	Upgrade	Barclays	Equal Weight → Overweight	$160 → $170
Oct-20-23	Resumed	UBS	Neutral	$157 → $150
Sep-29-23	Initiated	Raymond James	Outperform	$177
Jul-25-23	Initiated	William Blair	Mkt Perform
Jul-14-23	Initiated	HSBC Securities	Buy	$167
Apr-05-23	Downgrade	Argus	Buy → Hold

Show Previous Ratings

May-17-25 06:40AM	3 Magnificent Stocks That Are Passive Income Machines (Motley Fool)
May-16-25 03:09PM	Jim Cramer On AbbVie: Makes "Sense To Start a Position in the Stock" (Insider Monkey)
08:06AM	Pharma Stock Roundup: BAYRY Q1 Earnings, NVO & GSK's New Deals (Zacks)
May-15-25 03:26PM	FDA awards cancer drug approvals to AbbVie and MSD (Pharmaceutical Technology)
08:42AM	AbbVie Secures FDA Nod for New ADC Drug Emrelis in Lung Cancer (Zacks)
07:00AM	Loading…
07:00AM	AbbVie stakes $335M on a startups RNAi drugs (BioPharma Dive)
06:50AM	AbbVie and ADARx to develop siRNA therapeutics for multiple disease areas (Pharmaceutical Business Review)
06:49AM	AbbVie expands siRNA push with $335m ADARx deal (Pharmaceutical Technology)
05:11AM	FDA approves Roches MET protein expression detecting assay for NSQ-NSCLC (Medical Device Network)
May-14-25 07:02PM	Regeneron Upgraded as AbbVie Catches Policy Heat (GuruFocus.com) -5.62%
03:25PM	FDA Fast-Tracks AbbVie's New Lung Cancer Therapy Emrelis For Tough Lung Cancer Cases (Benzinga)
02:06PM	Calls of the Day: RobinHood, UnitedHealth, Abbvie and Lowe's (CNBC TV)
01:23PM	US FDA approves AbbVie's drug for a type of lung cancer (Reuters)
01:09PM	U.S. FDA Approves EMRELIS (telisotuzumab vedotin-tllv) for Adults With Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC) With High c-Met Protein Overexpression (PR Newswire)
10:40AM	AbbVie Inc. (ABBV): Among the Best Dividend Growth Stocks with High Yields (Insider Monkey)
10:24AM	Loading…
10:24AM	Pharma Stock Regeneron Is a Buy, Says Citi. But Be Cautious on AbbVie, Merck. (Barrons.com)
09:54AM	AbbVie, Merck cut to Neutral at Citi (Investing.com)
09:00AM	AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:55AM	AbbVie and ADARx Pharmaceuticals Announce Collaboration and License Option Agreement to Develop Next-Generation siRNA Therapies Across Multiple Therapeutic Areas (PR Newswire)
May-13-25 05:03PM	Is AbbVie Inc. (ABBV) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom? (Insider Monkey)
09:44AM	Q1 2025 Regenxbio Inc Earnings Call (Thomson Reuters StreetEvents)
07:36AM	Drug Stocks Recover as Trump's Order Proves Not as Bad as Feared (Zacks)
May-12-25 07:20PM	Trump's drug price order is part request, part threat: Analyst (Yahoo Finance Video)
04:58PM	Analyst Report: AbbVie Inc. (Morningstar Research)
04:25PM	S&P, Dow Pharma Stocks Boomerang On Drug-Pricing Order That Is 'All Bark' And 'Little Bite' (Investor's Business Daily)
03:50PM	How Trump could go about executing order to slash drug prices (Yahoo Finance Video)
02:35PM	Global Pharma Stocks Rebound as Investors See Hurdles in Trump Drug Plan (Investopedia)
10:44AM	Trump expected to sign order to slash US drug prices (Yahoo Finance Video)
10:00AM	S&P 500, Dow Jones Pharma Stocks Boomerang As Trump Outlines Drug-Price Reform (Investor's Business Daily)
09:09AM	US-China trade truce, April CPI, drug prices: 3 Things (Yahoo Finance Video)
09:00AM	Loading…
May-11-25 09:00AM	Recession Worries? Here's 1 of the Best Dividend Stocks for Turbulent Times (Motley Fool)
May-10-25 08:45AM	2 High-Yield Dividend Stocks to Buy in May and Hold Forever (Motley Fool)
04:11AM	AbbVie Inc. (ABBV): Among the Best Income Stocks to Invest in Now (Insider Monkey)
May-09-25 06:20AM	Is ProShares S&P 500 Dividend Aristocrats ETF (NOBL) a Strong ETF Right Now? (Zacks)
May-08-25 09:55AM	IRWD Stock Down 15% as Q1 Earnings & Revenues Miss Estimates (Zacks)
07:48AM	TEVA Beats on Q1 Earnings, Expects $700M Cost Savings by 2027, Stock Up (Zacks)
May-07-25 02:54PM	AbbVie Inc. (ABBV): A Bull Case Theory (Insider Monkey)
11:35AM	2024 Total Dividend Income And Portfolio Update (Seeking Alpha)
08:48AM	The Zacks Analyst Blog Highlights Johnson & Johnson and AbbVie (Zacks)
05:30AM	Trump Is Threatening Big Pharma With Tariffs. Tax Changes Might Work Better. (The Wall Street Journal)
04:55AM	Fidelity Select Health Care Portfolio Q1 2025 Commentary (Seeking Alpha)
May-06-25 10:13PM	If You Invested $10K In AbbVie Stock 10 Years Ago, How Much Would You Have Now? (Benzinga)
08:26AM	JNJ vs. ABBV: Which Pharma Powerhouse Has Better Growth Prospects? (Zacks)
08:00AM	AbbVie to Present at the Bank of America Securities Healthcare Conference (PR Newswire)
05:26AM	ChatGPT Stock Advice: AbbVie Inc. (ABBV) Among Top Stock Recommendations (Insider Monkey)
03:10AM	On tariffs and pricing, Big Pharma CEOs are waiting out the storm while planning for the worst (Pharma Voice)
12:36AM	1 Mega-Cap Stock Worth Your Attention and 2 to Keep Off Your Radar (StockStory)
May-04-25 04:49AM	Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash? (Motley Fool)
May-03-25 08:37AM	Invest in These ETFs to Prepare Your Portfolio for a Recession (Motley Fool)
May-02-25 11:34AM	AbbVie Stock: Using A Long-Term Leap Ratio Spread On This Pharma Giant (Investor's Business Daily)
10:07AM	Ardelyx: Revenue Misses And Losses Widen Amid XPHOZAH Uncertainty (Seeking Alpha)
07:02AM	3 Biotech Giants Gaining From U.S. Sales and Policy Shifts (MarketBeat)
05:45AM	Shareholders of Cerevel Therapeutics Holdings, Inc. Should Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights - ABBV (PR Newswire)
May-01-25 06:29PM	Transforming HR Leadership: Inside The Darla Moore Schools Standout MHR Program (Poets & Quants)
05:00PM	BOTOX Cosmetic (onabotulinumtoxinA) Continues its Mission of Empowering Entrepreneurs Through "The Confidence Project" (PR Newswire)
11:45AM	ClearBridge Value Fund Q1 2025 Commentary (Seeking Alpha)
10:20AM	ClearBridge Appreciation Fund Q1 2025 Commentary (Seeking Alpha)
09:35AM	ClearBridge Growth Portfolios Q1 2025 Commentary (Seeking Alpha)
09:30AM	ClearBridge Growth ESG Portfolios Q1 2025 Commentary (Seeking Alpha)
09:15AM	ClearBridge All Cap Growth Portfolios Q1 2025 Commentary (Seeking Alpha)
Apr-30-25 11:50PM	Franklin Global Equity Fund Q1 2025 Commentary (Seeking Alpha)
09:35PM	ClearBridge Growth Fund Q1 2025 Commentary (Seeking Alpha)
07:21AM	FDA approves AbbVies upadacitinib for giant cell arteritis (Pharmaceutical Technology)
Apr-29-25 08:32PM	Buy Pfizer (PFE) Stock for a Rebound After Crushing Q1 EPS Expectations? (Zacks)
08:07PM	Best Dividend Aristocrats For May 2025 (Seeking Alpha)
02:00PM	Final Trades: Netflix, Abbvie, iShares U.S. Industrials ETF and Sherwin Williams (CNBC TV)
09:00AM	AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
07:30AM	RINVOQ (upadacitinib) Receives U.S. FDA Approval for Giant Cell Arteritis (GCA) (PR Newswire)
03:10AM	United Therapeutics (UTHR) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Apr-28-25 07:02PM	Why AbbVie Stock Trounced the Market Today (Motley Fool)
05:07PM	S&P 500 Gains and Losses Today: AbbVie Stock Advances After Beat-and-Raise Earnings Report (Investopedia)
08:44AM	AbbVie Stock Rises Despite Risks as Earnings Beat Forecasts (Barrons.com)
07:51AM	ALX Oncologys CD47-blocker and Keytruda combo fails in two Phase II trials (Clinical Trials Arena)
07:47AM	3 Dividend Stocks to Buy and Hold for the Next Decade (Motley Fool)
05:18AM	Company News for Apr 28, 2025 (Zacks)
04:42AM	Should Investors Be Worried About Dividend King AbbVie? (Motley Fool)
03:04AM	Incyte (INCY) Q1 Earnings Report Preview: What To Look For (StockStory)
03:04AM	Regeneron (REGN) Reports Earnings Tomorrow: What To Expect (StockStory)
Apr-27-25 11:40PM	Why AbbVie's Stock Is A Strong Buy After Q1 2025 Results (Seeking Alpha)
02:58PM	AbbVie Inc. (ABBV): Among Billionaire Ken Fisher's Healthcare Stock Picks with Massive Upside Potential (Insider Monkey)
Apr-26-25 06:05PM	4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off (Motley Fool)
12:20PM	China weighs U.S. tariff exemptions, Alphabet reports Q1 beat: Morning Buzz (TipRanks)
03:04AM	AbbVie Inc (ABBV) Q1 2025 Earnings Call Highlights: Strong Growth in Immunology and ... (GuruFocus.com)
01:11AM	Q1 2025 AbbVie Inc Earnings Call (Thomson Reuters StreetEvents)
Apr-25-25 10:07PM	How Much Would It Take To Earn $100 A Month From AbbVie Stock (Benzinga)
09:45PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
05:17PM	Why AbbVie Stock Topped the Market Today (Motley Fool)
05:17PM	AbbVie's First Quarter Beat And Raise Leaves Room For More (Seeking Alpha)
04:38PM	Is AbbVie Inc. (ABBV) the Best Dividend Stock to Buy for Long-Term Passive Income? (Insider Monkey)
04:05PM	AbbVie Hikes Its Outlook On The Back Of Two Powerhouse Drugs (Investor's Business Daily)
04:00PM	AbbVie: Q1 Earnings Reinforce Positive Momentum (Seeking Alpha)
02:00PM	AbbVie Q1 Earnings Review: Typically Strong Performance, Aesthetics Aside (Seeking Alpha)
01:18PM	AbbVie Beats on Q1 Earnings & Sales, Raises '25 EPS View (Zacks)
01:11PM	Bitcoin extends rally, AbbVie earnings beat, Phillips 66 miss (Yahoo Finance Video)
12:49PM	AbbVie Stock Rises on Stronger-Than-Expected Results, Profit Outlook Lift (Investopedia)
12:15PM	Analyst Report: AbbVie Inc. (Morningstar Research)
12:14PM	AbbVie Inc. (ABBV) Q1 2025 Earnings Call Transcript (Seeking Alpha)
12:02PM	Drugmaker Abbvie Ramps Up Domestic Manufacturing Plans on Tariff Threats (The Wall Street Journal)
11:33AM	AbbVie warns of tariff exposure, U.S. policy risks while boosting forecast (Investing.com)

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Stewart Jeffrey Ryan	EVP, CHIEF COMMERCIAL OFFICER	Mar 31 '25	Option Exercise	79.02	25,700	2,030,814	112,066	Apr 02 05:00 PM
Stewart Jeffrey Ryan	EVP, CHIEF COMMERCIAL OFFICER	Mar 31 '25	Sale	210.08	58,832	12,359,504	53,234	Apr 02 05:00 PM
Stewart Jeffrey Ryan	Officer	Mar 31 '25	Proposed Sale	210.09	58,832	12,359,897		Mar 31 05:30 PM
Reents Scott T	EVP, CHIEF FINANCIAL OFFICER	Mar 14 '25	Sale	212.34	17,644	3,746,527	11,577	Mar 18 05:00 PM
Reents Scott T	Officer	Mar 14 '25	Proposed Sale	212.35	17,644	3,746,628		Mar 14 04:34 PM
GONZALEZ RICHARD A	Director	Feb 28 '25	Sale	205.11	92,460	18,964,471	395,097	Mar 04 05:00 PM
GONZALEZ RICHARD A	Director	Mar 03 '25	Sale	210.53	6,168	1,298,549	388,929	Mar 04 05:00 PM
Siatis Perry C	EVP, GC AND SECRETARY	Mar 03 '25	Option Exercise	159.88	18,008	2,879,040	22,627	Mar 04 05:00 PM
Siatis Perry C	EVP, GC AND SECRETARY	Mar 03 '25	Sale	210.00	18,008	3,781,680	4,619	Mar 04 05:00 PM
Siatis Perry C	EVP, GC AND SECRETARY	Feb 28 '25	Sale	206.30	9,892	2,040,722	4,619	Mar 04 05:00 PM
RICHMOND TIMOTHY J.	EVP, CHIEF HR OFFICER	Mar 03 '25	Sale	210.45	21,250	4,472,039	6,130	Mar 04 05:00 PM
GONZALEZ RICHARD A	Officer	Mar 03 '25	Proposed Sale	210.53	6,168	1,298,550		Mar 03 05:57 PM
PERRY C SIATIS	Officer	Mar 03 '25	Proposed Sale	210.00	18,008	3,781,680		Mar 03 04:28 PM
TIMOTHY RICHMOND	Officer	Mar 03 '25	Proposed Sale	210.46	21,250	4,472,184		Mar 03 04:08 PM
GONZALEZ RICHARD A	Officer	Feb 28 '25	Proposed Sale	205.11	92,460	18,964,882		Feb 28 05:37 PM
Buckbee Kevin K	SVP, CONTROLLER	Feb 26 '25	Option Exercise	98.48	16,260	1,601,313	28,906	Feb 28 05:00 PM
Buckbee Kevin K	SVP, CONTROLLER	Feb 26 '25	Sale	203.41	18,944	3,853,372	11,496	Feb 28 05:00 PM
RICHMOND TIMOTHY J.	EVP, CHIEF HR OFFICER	Feb 26 '25	Option Exercise	114.36	22,210	2,539,936	66,494	Feb 28 05:00 PM
RICHMOND TIMOTHY J.	EVP, CHIEF HR OFFICER	Feb 26 '25	Sale	202.90	29,917	6,070,036	44,284	Feb 28 05:00 PM
PERRY C SIATIS	Officer	Feb 28 '25	Proposed Sale	206.31	9,892	2,040,790		Feb 28 04:12 PM
Buckbee Kevin K	Officer	Feb 26 '25	Proposed Sale	203.41	18,944	3,853,398		Feb 26 05:47 PM
TIMOTHY RICHMOND	Officer	Feb 26 '25	Proposed Sale	202.90	29,917	6,070,176		Feb 26 04:04 PM
Siatis Perry C	EVP, GC AND SECRETARY	Feb 20 '25	Sale	197.90	5,778	1,143,453	22,381	Feb 24 05:00 PM
PERRY C SIATIS	Officer	Feb 20 '25	Proposed Sale	197.90	5,778	1,143,492		Feb 20 04:10 PM
Buckbee Kevin K	SVP, CONTROLLER	Dec 16 '24	Option Exercise	93.50	1,800	168,300	8,783	Dec 18 05:00 PM
Buckbee Kevin K	SVP, CONTROLLER	Dec 16 '24	Sale	172.24	1,800	310,032	6,983	Dec 18 05:00 PM
Buckbee Kevin K	Officer	Dec 16 '24	Proposed Sale	172.25	1,800	310,045		Dec 16 05:34 PM
Hudson Thomas J	Officer	Aug 08 '24	Proposed Sale	189.08	49,170	9,297,210		Aug 08 05:40 PM
GONZALEZ RICHARD A	EXECUTIVE CHAIRMAN OF BOARD	Aug 05 '24	Sale	186.52	66,500	12,403,580	446,599	Aug 07 05:00 PM
Hudson Thomas J	Officer	Aug 07 '24	Proposed Sale	187.62	101,886	19,115,380		Aug 07 04:22 PM
GONZALEZ RICHARD A	Officer	Aug 05 '24	Proposed Sale	187.36	66,500	12,459,360		Aug 05 10:54 AM
GONZALEZ RICHARD A	EXECUTIVE CHAIRMAN OF BOARD	Jul 17 '24	Option Exercise	77.49	282,845	21,919,048	795,944	Jul 19 04:40 PM
GONZALEZ RICHARD A	EXECUTIVE CHAIRMAN OF BOARD	Jul 17 '24	Sale	175.00	282,845	49,497,875	513,099	Jul 19 04:40 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ABBV

Abbvie Inc

Upgrade your FINVIZ experience